📊 Statistics
- Analyst 1 Year Price Target:
$1.17
- Upside/Downside from Analyst Target:
15.79%
- Broker Call:
7
- Dividend Minimum 3 Year Yield:
2.31%
- EPS Growth Range (1Y):
0-10%
- Net Income Growth Range (1Y):
0-10%
- Revenue Growth Range (1Y):
0-10%
-
Upcoming Earnings Date:
2026-02-23
💰 Dividend History
📅 SGX Earnings Announcements for BSL
Raffles Medical Group Ltd (BSL)
Market: SGX |
Currency: SGD
Address: 585 North Bridge Road
Raffles Medical Group Ltd provides integrated private healthcare services primarily in Singapore, Greater China, Vietnam, Cambodia, and Japan. The company operates through Healthcare Services, Hospital Services, Investment Holdings, and Insurance Services segments. Its Raffles Hospital, a tertiary care hospital that offers a range of medical and surgical facilities include day angiography suites, operating theatres, delivery suites, intensive care unit, neonatal intensive care unit, radiology, clinical laboratory, and dental services. In addition, the company offers emergency services, family medicine services, health screening, minor surgery, and various specialist clinic services. Further, it trades in pharmaceutical and nutraceutical products, and diagnostic equipment; and provides management and consultancy services. Additionally, the company engages in the operation of medical and dental clinics and other general medical services; provides medical examination and treatment services; operation of medical laboratory and imaging centre; and provision of health insurance services. Raffles Medical Group Ltd was founded in 1976 and is based in Singapore. The company operates as a subsidiary of Raffles Medical Holdings Pte Ltd.
Show more
📈 Raffles Medical Group Ltd Historical Chart
🧾 Recent Financial Statement Analysis
📰 Related News & Research
Showing results matched by any of: BSL.SI, Raffles Medical Group Ltd, Raffles Medical, RFMD SP, RAFFLES MEDICAL GROUP LTD, RAFFLES MEDICAL GROUP
July 29, 2025
UOB Kay Hian Date of Report: 29 July 2025 Raffles Medical Group: Margins Resilient, China Turnaround in Sight as 1H25 Results Slightly Miss Expectations Overview: Raffles Medical Group Financial Snapshot and Market Position Raffles Medical Group (RFMD), a leading integrated…
July 29, 2025
CGS International July 29, 2025 Raffles Medical Group: Incremental Growth, China Expansion, and Peer Analysis – A Deep Dive into Asia’s Healthcare Leaders Overview: Modest Growth Amid Insurance Headwinds Raffles Medical Group (RMG) continues to demonstrate steady organic growth, reporting…
July 8, 2025
Broker: UOB Kay Hian Date of Report: 8 July 2025 Raffles Medical Group: Earnings Growth on Track Despite Margin Pressures – Is Now the Time to Buy? Overview: Raffles Medical Group’s Position and Outlook Raffles Medical Group (RFMD) stands as…
June 27, 2025
Wall Street banks may be on the cusp of a massive windfall as the U.S. Federal Reserve proposes a major revision to capital rules. Analysts estimate the change could unlock as much as US$6 trillion in balance sheet capacity and…
April 26, 2025
Maybank Research Pte Ltd April 23, 2025 Raffles Medical Group: Strong Immunity – Strategic Shanghai Collaboration Drives Target Price Increase Executive Summary Raffles Medical Group (RFMD SP) has recently forged a strategic agreement with an affiliate of Shanghai Jiao Tong…
April 16, 2025
CGS International Securities Pte. Ltd. April 16, 2025 Trendspotter: Raffles Medical Group Ltd - Uptrend in an Early Stage The global market experienced significant fluctuations as President Donald Trump's evolving tariff war with major trade partners showed little signs of…
September 2, 2024
Wilmar International Ltd (WIL SP) - Benefiting from Higher Swine Prices and Stronger Currencies Recommendation: ADD Target Price: S$3.64 Stop Loss: None specified Date of Recommendation: 30th August 2024 Broker: CGS-CIMB Securities Investment Thesis: Wilmar International Ltd, a leading agribusiness…
